Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Prevnar
Description:
A brand of pneumococcal conjugate vaccine used to protect against infections caused by Streptococcus pneumoniae.
Primary topic:
Pneumonia and Respiratory Infections (59%)
Related topics:
Pneumonia and Respiratory Infections (59%),
Bacterial Infections and Vaccines (7%)
Wikidata ID:
wiki/Q7205991
OpenAlex ID:
keywords/prevnar
Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
2000
·
PubMed
·
387
Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines
2006
·
Sandra Romero-Steiner
, Carl E. Frasch
, et al.
·
Clinical and Vaccine Immunology
·
226
Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis
2000
·
Gary D. Overturf
, Ex-Officio
, et al.
·
PEDIATRICS
·
218
Historical Changes in Pneumococcal Serogroup Distribution: Implications for the Era of Pneumococcal Conjugate Vaccines
2002
·
Daniel R. Feikin
, Keith P. Klugman
·
Clinical Infectious Diseases
·
184
Establishment of a New Human Pneumococcal Standard Reference Serum, 007sp
2011
·
D. Goldblatt
, B. D. Plikaytis
, et al.
·
Clinical and Vaccine Immunology
·
118
In Vivo Humoral Immune Responses to Isolated Pneumococcal Polysaccharides Are Dependent on the Presence of Associated TLR Ligands
2005
·
Goutam Sen
, Abdul Q Khan
, et al.
·
The Journal of Immunology
·
111
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
2007
·
Michael Haber
, Albert Barskey
, et al.
·
Vaccine
·
96
Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
2011
·
Julie M. Skinner
, Lani Indrawati
, et al.
·
Vaccine
·
92
Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases
2004
·
K. L. O'Brien
, Mathuram Santosham
·
American Journal of Epidemiology
·
72
A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo
2014
·
S. Deng
, L. Bai
, et al.
·
Chemical Science
·
50
Streptococcus pneumoniae Sepsis and Meningitis During the Penicillin Prophylaxis Era in Children With Sickle Cell Disease
2002
·
Jeffrey Hord
, Rebecca Byrd
, et al.
·
Journal of Pediatric Hematology/Oncology
·
49
Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar)
2006
·
Daniel J Isaacman
, Mark A Fletcher
, et al.
·
Vaccine
·
47
Update on the Use of Conjugate Pneumococcal Vaccines in Childhood
2010
·
Shalini Desai
, Allison McGeer
, et al.
·
Canada Communicable Disease Report
·
36
PDF
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®)
2010
·
Mark H. Rozenbaum
, Albert Jan van Hoek
, et al.
·
Vaccine
·
33
Radiographic Pneumonia in Young, Highly Febrile Children With Leukocytosis Before and After Universal Conjugate Pneumococcal Vaccination
2009
·
Maia S. Rutman
, Richard Bachur
, et al.
·
Pediatric Emergency Care
·
31
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
2005
·
L JACKSON
, K NEUZIL
, et al.
·
Vaccine
·
28
A Case of Recurrent Sterile Abscesses following Vaccination: Delayed Hypersensitivity to Aluminum
2007
·
Heather K. Lehman
, Howard S. Faden
, et al.
·
The Journal of Pediatrics
·
27
Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998–2004
2006
·
George G. Zhanel
, Xi Wang
, et al.
·
International Journal of Antimicrobial Agents
·
27
Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Third and Fourth Dose
2004
·
Annals of Pharmacotherapy
·
26
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study
2017
·
Katrin L. Dubischar
, Vera Kadlecek
, et al.
·
The Pediatric Infectious Disease Journal
·
25
Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada
2002
·
Shalini N. Desai
, James D. Kellner
, et al.
·
The Pediatric Infectious Disease Journal
·
21
Characterization of High Molecular Weight Pneumococcal Conjugate by SEC-MALS and AF4-MALS
2022
·
James Z. Deng
, Jason Lin
, et al.
·
Polymers
·
19
PDF
Local Vaccine Site Reactions and Contact Allergy to Aluminum
2011
·
Mara G. Beveridge
, Ingrid C. Polcari
, et al.
·
Pediatric Dermatology
·
17
PDF
Updated Recommendation From the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated
2008
·
JAMA
·
16
PDF
Physicians' Early Challenges Related to the Pneumococcal Conjugate Vaccine
2001
·
Matthew M. Davis
, Margie Andreae
, et al.
·
Ambulatory Pediatrics
·
16
Show more works
View as search
Works count:
112
Citation count:
2,145
Year
Topic
Type